Due to these interactions as well as its increased expression in tumor cells, PRMT5 was linked to cancer proliferation, migration, epithelial to mesenchymal transition, invasion, and metastasis (98) and was suggested as potential therapeutic anti-cancer target (99, 100). The gene discussed is PRMT5; the disease is cancer.